- Radboud Repository
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Hoeven, J.J.M. van der"
Now showing items 1-49 of 49
-
Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry Zeijl, M.C.T. van; Wreede, L.C. de; Eertwegh, A.J. van den; Wouters, M.; Jochems, A.; Schouwenburg, M.G.; Aarts, M.J.; Akkooi, A.C. van; Berkmortel, F. van den; Groot, J.W.B. de; et al.2021, Article / Letter to editor (European Journal of Cancer, vol. 144, (2021), pp. 242-251)
sine al.
-
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial Groot, S. de; Lugtenberg, R.T.; Cohen, D.; Welters, M.J.; Ehsan, I.; Vreeswijk, M.P.G.; Smit, V.; Graaf, H. de; Heijns, J.B.; Portielje, J.E.; et al.2020, Article / Letter to editor (Nature Communications, vol. 11, iss. 1, (2020), article 3083)
sine al.
-
Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study Zeijl, M.C.T. van; Haanen, J.; Wouters, M.; Wreede, L.C. de; Jochems, A.; Aarts, M.J.; Berkmortel, F. van den; Groot, J.W.B. de; Hospers, G.A.; Kapiteijn, E.W.; et al.2020, Article / Letter to editor (Journal of Immunotherapy (1997), vol. 43, iss. 8, (2020), pp. 256-264)
sine al.
-
Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry Verheijden, R.J.; May, A.M.; Blank, C.U.; Aarts, M.J.; Berkmortel, F. van den; Eertwegh, A.J. van den; Groot, J.W.B. de; ; ; Hospers, G.A.; et al.2020, Article / Letter to editor (Clinical Cancer Research, vol. 26, iss. 9, (2020), pp. 2268-2274)
sine al.
-
-
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE) Samsom, K.G.; Bosch, L.J.; Schipper, L.J.; Roepman, P.; Bruijn, E. de; Hoes, L.R.; Riethorst, I.; Schoenmaker, L.; Kolk, L.E. van der; Retèl, V.P.; et al.2020, Article / Letter to editor (BMC Medical Genomics, vol. 13, iss. 1, (2020), article 169)
sine al.
-
Lower risk of severe checkpoint inhibitor toxicity in more advanced disease Verheijden, R.J.; May, A.M.; Blank, C.U.; Veldt, A.A.M. van der; ; Aarts, M.J.; Berkmortel, F. van den; Eertwegh, A.J. van den; Groot, J.W.B. de; ; et al.2020, Article / Letter to editor (Esmo Open, vol. 5, iss. 6, (2020), article e000945)
sine al.
-
-
-
-
-
Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry Jochems, A.; Kooij, M.K. van der; Fiocco, M.; Schouwenburg, M.G.; Aarts, M.J.; Akkooi, A.C. van; Berkmortel, F. van den; Blank, C.U.; Eertwegh, A.J. van den; Franken, M.G.; et al.2019, Article / Letter to editor (Cancers, vol. 11, iss. 7, (2019), article E1007)
sine al.
-
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy ; Willigen, W.W. van; ; ; ; Werner, J.E.M.; ; ; Groot, J.W.B. de; ; et al.2019, Article / Letter to editor (Annals of Surgical Oncology, vol. 26, iss. 12, (2019), pp. 3945-3952)
sine al.
-
-
-
-
-
-
-
-
Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes Schouwenburg, M.G.; Jochems, A.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J. van den; Haanen, J.; Zeijl, M.C.T. van; Aarts, M.J.; Akkooi, A.C. van; Berkmortel, F. van den; et al.2018, Article / Letter to editor (Melanoma Research, vol. 28, iss. 4, (2018), pp. 326-332)
sine al.
-
-
-
-
[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry] Zeijl, M.C.T. van; Eertwegh, A.J. van den; Wouters, M.; Jochems, A.; Schouwenburg, M.G.; Haanen, J.; Aarts, M.J.; Berkmortel, F. van den; Groot, J.W.B. de; Hospers, G.A.; et al.2018, Article / Letter to editor (Nederlands Tijdschrift voor Geneeskunde, vol. 162, (2018), article D2420)
sine al.
-
-
-
-
-
Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands Jochems, A.; Schouwenburg, M.G.; Leeneman, B.; Franken, M.G.; Eertwegh, A.J. van den; Haanen, J.B.; Gelderblom, H.; Groot, C.A; Aarts, M.J.; Berkmortel, F.W. van den; et al.2017, Article / Letter to editor (European Journal of Cancer, vol. 72, (2017), pp. 156-165)
sine al.
-
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial Schneider, T.C.; Wit, D. de; Links, T.P.; ; ; Gelderblom, H.; Roozen, I.C.; Bos, M.; Corver, W.E.; Wezel, T. van; et al.2017, Article / Letter to editor (Journal of Clinical Endocrinology and Metabolism, vol. 102, iss. 2, (2017), pp. 698-707)
sine al.
-
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01) Charehbili, A.; Hamdy, N.A.; Smit, V.T.; Kessels, L; Bochove, A. van; ; Putter, H.; Meershoek-Klein Kranenbarg, E.; Leeuwen-Stok, A.E. van; ; et al.2016, Article / Letter to editor (Breast, vol. 25, (2016), pp. 69-74)
sine al.
-
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer Wit, D. de; Schneider, T.C.; Moes, D.J.; Roozen, C.F.; Hartigh, J. den; Gelderblom, H.; Guchelaar (LUMC), H.J.; ; Links, T.P.; Kapiteijn, E.; et al.2016, Article / Letter to editor (Cancer Chemotherapy and Pharmacology, vol. 78, iss. 1, (2016), pp. 63-71)
sine al.
-
-
-
-
-
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01) Groot, S. de; Charehbili, A.; ; Mooyaart, A.L.; Dekker-Ensink, N.G.; Ven, S. van de; Janssen, L.G.; Swen, J.J.; Smit, V.T.; Heijns, J.B.; et al.2016, Article / Letter to editor (Breast Cancer Research, vol. 18, iss. 1, (2016), pp. 3)
sine al.
-
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial Schneider, T.C.; Wit, D. de; Links, T.P.; ; ; Gelderblom, H.; Wezel, T. van; Eijk, R. van; Morreau, H.; Guchelaar (LUMC), H.J.; et al.2015, Article / Letter to editor (International Journal of Endocrinology, vol. 2015, (2015), pp. 348124)
sine al.
-
A phase 1/2 study combining gemcitabine, Pegintron and p53 SLP vaccine in patients with platinum-resistant ovarian cancer Dijkgraaf, E.M.; Santegoets, S.J.; Reyners, A.K.; Goedemans, R.; Nijman, H.W.; Poelgeest, M.I.E. van; Erkel, A.R. van; Smit, V.T.; Daemen, T.A.; ; et al.2015, Article / Letter to editor (Oncotarget, vol. 6, iss. 31, (2015), pp. 32228-32243)
sine al.
-
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-alpha2b in patients with recurrent epithelial ovarian cancer Dijkgraaf, E.M.; Santegoets, S.J.; Reyners, A.K.; Goedemans, R.; Wouters, M.C.; Kenter, G.G.; Erkel, A.R. van; Poelgeest, M.I.E. van; Nijman, H.W.; ; et al.2015, Article / Letter to editor (Annals of Oncology, vol. 26, iss. 10, (2015), pp. 2141-2149)
sine al.
-
-
Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach Morgans, A.K.; Bommel, A.C. van; Stowell, C.; Abrahm, J.L.; Basch, E.; Bekelman, J.E.; Berry, D.L.; Bossi, A.; Davis, I.D.; Reijke, T.M. de; et al.2015, Article / Letter to editor (European Urology, vol. 68, iss. 5, (2015), pp. 891-898)
sine al.
-
The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study Groot, S. de; Vreeswijk, M.P.; Welters, M.J.; Gravesteijn, G.; Boei, J.J.; Jochems, A.; Houtsma, D.; Putter, H.; ; Nortier, J.W.; et al.2015, Article / Letter to editor (BMC Cancer, vol. 15, (2015), article 652)
sine al.
-
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group Simkens, L.H.; Tinteren, H. van; May, A.; Tije, A.J. Ten; Creemers, G.J.; Loosveld, O.J.; Jongh, F.E. de; Erdkamp, F.L.; ; Torren, A.M. van der; et al.2015, Article / Letter to editor (The Lancet (London), vol. 385, iss. 9980, (2015), pp. 1843-1852)
sine al.
-
-
-
-
Now showing items 1-49 of 49
Upload Full Text